Manuscript

PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumab

May 29, 2018

Published in: OncoImmunology

Cancers & tumors Urothelial carcinoma PD-L2 OncoImmunology (journal)Oncology